IVUS as ESSENTIAL TOOL IN COMPLEX SCENARIO - part 1
Learn the ABCs of how to use IVUS in clinical practice
Learn the ABCs of how to use IVUS in clinical practice
Philips offers a variety of live courses and on-demand programs led by leaders in the coronary vascular community which allow you to discover Philips’ cardiology solutions and are designed to strengthen clinical confidence and improve patient outcomes
Dr. AK does his best to treat patients on the basis of appositeness of the procedure and not technical intricacy. He...
Dr. AK does his best to treat patients on the basis of appositeness of the procedure and not technical intricacy. He strongly thinks that the focus is on the interventional cardiologist to be reliably trained so that the right patients (irrespective of the intricacy of the procedure) could be treated, and not only the ones the cardiologist is able to do due to his/her limited competences. This central philosophy has allowed Dr. AK to not just be a distinguished operator but also train thousands of cardiologists worldwide in intricate coronary interventions, such as chronic total occlusion PCI (believed to be the most intricate angioplasty process), over the past six years. He has carried out several extremely intricate procedures in Asia and the United States with great success and a flawless safety record. Furthermore, he has been trained in structural interventions and peripheral angioplasties at the Cleveland Clinic. After completing his MBBS from Madras Medical College in India, he became a part of several renowned institutes like the Geisinger Medical Center, University of Maryland, and Cleveland Clinic (all in the United States). Moreover, he is a member of the American College of Cardiology and Society for Cardiovascular Angiography and Interventions. Today, Arun Kalyanasundaram is a renowned leader in the domain of Chronic Total Occlusion Interventions in the United States and rest of the world. He has served in many leadership roles such as Chief of Cardiology and Cath Lab Director at Highline Medical Centre and Head of the CTO PCI programme at Swedish Medical Centre (both in the United States). He acts as a consultant to many firms in the domain of CTOs and is one of the most popular proctors for teaching this process in the United States and globally. Apart from holding an academic position at the University of Washington, Seattle, he has also been a full-time proctor for CTOs in Asia Pacific and has assisted in propagating the “Hybrid CTO” methodology. He also has several publications in the domain and has carried out chaired sessions and live cases. He is a revered speaker in this domain. Currently, he is the chief of Cardiology at Chennai’s Promed Hospital. He is also an Honorary Director, Interventional Cardiology at Fortis Escorts Heart Institute (New Delhi), and the Head of the CTO PCI program as well, which is the first of its kind in the country. He has established the CHIP-CTO INDIA [COMPLEX HIGH RISK INDICATED PATIENTS (CHIP) – CHRONIC TOTAL OCCLUSION (CTO)] conference, along with some other leaders in interventional cardiology in India, to teach cardiologists how to tackle intricate coronary interventions, which are high-risk and chronic total occlusions.
A chief of department for interventional cardiology at Clinic for Cardiology and Conservative Intensive Care Medicine...
A chief of department for interventional cardiology at Clinic for Cardiology and Conservative Intensive Care Medicine Augusta Krankenhaus Duesseldorf, Germany. Features in 5 videos on Wondr Medical. Markus Meyer-Gessner generally speaks on Chronic Total Occlusion (CTO), Stable Coronary Artery Disease (CAD), and Intravascular Ultrasound (IVUS).
Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK....
Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al- Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.
Dr Roberto Garbo is an Interventional Cardiologist in Maria Pia Hospital GVM Care & Research, Turin, Italy. He is a...
Dr Roberto Garbo is an Interventional Cardiologist in Maria Pia Hospital GVM Care & Research, Turin, Italy. He is a Director of CTO and Complex PCI program, Board member of EuroCTO Club since 2017 and IVUS guided CTO expert in both antegrade and retrograde approach. Dr Garbo is a Director of Turin CTO&CHIp Live course.